12:00 AM
 | 
Jun 05, 2000
 |  BC Week In Review  |  Clinical News  |  Regulatory

Pegintron peginterferon alfa-2b regulatory update

ENZN partner SGP received European Union approval to market its Pegintron as a once-weekly monotherapy to treat adult...

Read the full 68 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >